Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer H E Baker

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenograftsJennifer H E Baker, Kirstin E Lindquist, Lynsey A Huxham, et al.
DNA Repair|May 15, 2024
DNA-PK inhibitor AZD7648 is a more portent radiosensitizer than PARP inhibitor Olaparib in BRCA1/2 deficient tumorsTaixiang Wang, Alastair H Kyle, Jennifer H E Baker, et al.
Contrast Media & Molecular Imaging|August 14, 2015
Multi-modal magnetic resonance imaging and histology of vascular function in xenografts using macromolecular contrast agent hyperbranched polyglycerol (HPG-GdF)Jennifer H E Baker, Kelly C McPhee, Firas Moosvi, et al.
Molecular Cancer Therapeutics|May 23, 2024
Radiation and Chemo-Sensitizing Effects of DNA-PK Inhibitors Are Proportional in Tumors and Normal TissuesJennifer H E Baker, Alastair H Kyle, Nannan A Liu, et al.
Plos One|April 16, 2011
Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltrationSteven Maltby, Spencer Freeman, Matthew J Gold, et al.
Bioconjugate Chemistry|February 7, 2012
Hyperbranched polyglycerols as trimodal imaging agents: design, biocompatibility, and tumor uptakeKatayoun Saatchi, Peter Soema, Nikolaus Gelder, et al.
Plos One|November 9, 2013
Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxinJennifer H E Baker, Alastair H Kyle, Kirsten L Bartels, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 12, 2024
Detection of FLASH-radiotherapy tissue sparing in a 3D-spheroid model using DNA damage response markersAlastair H Kyle, Tania Karan, Jennifer H E Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2011
In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancerClement Mugabe, Yoshiyuki Matsui, Alan I So, et al.
Cancer Research|March 7, 2014
Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanismAlexandre Patenaude, Megan Fuller, Linda Chang, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Direct visualization of heterogeneous extravascular distribution of trastuzumab in human epidermal growth factor receptor type 2 overexpressing xenograftsJennifer H E Baker, Kirstin E Lindquist, Lynsey A Huxham, et al.
DNA Repair|May 15, 2024
DNA-PK inhibitor AZD7648 is a more portent radiosensitizer than PARP inhibitor Olaparib in BRCA1/2 deficient tumorsTaixiang Wang, Alastair H Kyle, Jennifer H E Baker, et al.
Contrast Media & Molecular Imaging|August 14, 2015
Multi-modal magnetic resonance imaging and histology of vascular function in xenografts using macromolecular contrast agent hyperbranched polyglycerol (HPG-GdF)Jennifer H E Baker, Kelly C McPhee, Firas Moosvi, et al.
Molecular Cancer Therapeutics|May 23, 2024
Radiation and Chemo-Sensitizing Effects of DNA-PK Inhibitors Are Proportional in Tumors and Normal TissuesJennifer H E Baker, Alastair H Kyle, Nannan A Liu, et al.
Plos One|April 16, 2011
Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltrationSteven Maltby, Spencer Freeman, Matthew J Gold, et al.
Bioconjugate Chemistry|February 7, 2012
Hyperbranched polyglycerols as trimodal imaging agents: design, biocompatibility, and tumor uptakeKatayoun Saatchi, Peter Soema, Nikolaus Gelder, et al.
Plos One|November 9, 2013
Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxinJennifer H E Baker, Alastair H Kyle, Kirsten L Bartels, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 12, 2024
Detection of FLASH-radiotherapy tissue sparing in a 3D-spheroid model using DNA damage response markersAlastair H Kyle, Tania Karan, Jennifer H E Baker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 2, 2011
In vivo evaluation of mucoadhesive nanoparticulate docetaxel for intravesical treatment of non-muscle-invasive bladder cancerClement Mugabe, Yoshiyuki Matsui, Alan I So, et al.
Cancer Research|March 7, 2014
Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanismAlexandre Patenaude, Megan Fuller, Linda Chang, et al.
Pageof 3